Illumina, Inc.
26
5
8
12
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.5%
3 terminated/withdrawn out of 26 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
8%
1 of 12 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (26)
Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project
Role: collaborator
Ultrafast Whole Genome Sequencing for Childhood Cancer
Role: collaborator
Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention
Role: collaborator
Genomic Uniformed-Screening Against Rare Disease In All Newborns
Role: collaborator
Early Check: Expanded Screening in Newborns
Role: collaborator
NeuralNET Cerebral Palsy Pilot Study
Role: collaborator
Solving Riddles Through Sequencing
Role: collaborator
NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology
Role: lead
CardioSeq: Impact of WGS in Individuals With CVD
Role: lead
iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders
Role: lead
Cell-free DNA Analysis of Chromosome Anomalies in Early Pregnancy Loss
Role: collaborator
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Role: collaborator
Prospective Electronic Polygenic Risk Study - Second Phase
Role: collaborator
Prospective Electronic Polygenic Risk Study
Role: collaborator
Collection of Whole Blood Specimens in Pregnant Women
Role: lead
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers
Role: lead
Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel
Role: lead
Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population
Role: lead
A Study to Examine the Clinical Value of Comprehensive Genomic Profiling Performed by Belgian NGS Laboratories: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Centre
Role: collaborator
NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
Role: lead